NCT07149857
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07149857
Title A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel (CARTITUDE-10)
Acronym CARTITUDE-10
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP | AUS


No variant requirements are available.